Triggering neurotrophic factor actions through adenosine A2A receptor activation: implications for neuroprotection
- 25 August 2009
- journal article
- review article
- Published by Wiley in British Journal of Pharmacology
- Vol. 158 (1), 15-22
- https://doi.org/10.1111/j.1476-5381.2009.00157.x
Abstract
G protein coupled receptors and tropomyosin-related kinase (Trk) receptors have distinct structure and transducing mechanisms; therefore, cross-talk among them was unexpected. Evidence has, however, accumulated showing that tonic adenosine A2A receptor activity is a required step to allow synaptic actions of neurotrophic factors, namely upon synaptic transmission at both pre- and post-synaptic level as well as upon synaptic plasticity. An enhancement of A2A receptor tonus upon ageing may partially compensate the loss of TrkB receptors, rescuing to certain degree the facilitatory action of brain derived neurotrophic factor in aged animals, which might prove particularly relevant in the prevention of neurodegeneration upon ageing. A2A receptors also trigger synaptic actions of other neurotrophic factors, such as glial derived neurotrophic factor at dopaminergic striatal nerve endings. The growing evidence that tonic adenosine A2A receptor activity is a crucial step to allow actions of neurotrophic factors in neurones will be reviewed and discussed in the light of therapeutic strategies for neurodegenerative diseases. British Journal of Pharmacology (2009) 158, 15-22; doi:10.1111/j.1476-5381.2009.00157.x; published online 5 June 2009Keywords
This publication has 87 references indexed in Scilit:
- GDNF control of the glutamatergic cortico‐striatal pathway requires tonic activation of adenosine A2A receptorsJournal of Neurochemistry, 2009
- Adenosine receptor A 2A -R contributes to motoneuron survival by transactivating the tyrosine kinase receptor TrkBProceedings of the National Academy of Sciences of the United States of America, 2007
- Adenosine A2A receptors modulate BDNF both in normal conditions and in experimental models of Huntington’s diseasePurinergic Signalling, 2007
- Suppression of kindling epileptogenesis by adenosine releasing stem cell-derived brain implantsBrain, 2007
- Is More Neurogenesis Always Better?Science, 2007
- Purinergic signalling in neuron–glia interactionsNature Reviews Neuroscience, 2006
- Rapid Tolerance to Focal Cerebral Ischemia in Rats is Attenuated by Adenosine A1 Receptor AntagonistJournal of Cerebral Blood Flow & Metabolism, 2002
- Brain-derived neurotrophic factor in the control human brain, and in Alzheimer’s disease and Parkinson’s diseaseProgress in Neurobiology, 2001
- Fine-tuning neuromodulation by adenosineTrends in Pharmacological Sciences, 2000
- Modification of A-i and A2a adenosine receptor binding in aged striatum, hippocampus and cortex of the ratNeuroReport, 1995